Shikari® (S-ATSEM) Anti-Semaglutide ELISA w/confirmation
SEM-QNS-OZE
Enzyme immunoassay for the quantitative determination of antibodies to Semaglutide (Ozempic®) antibodies in human serum and plasma.
This kit has been especially developed for the quantitative determination of anti-semaglutide antibodies in serum and plasma samples.
The Matriks Biotek Antibody to Semaglutide ELISA Kit can be efficiently used for monitoring anti-Semaglutide antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-semaglutide antibodies.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system.
Research Use Only (RUO)
For technical inquiry, IFU and other relevant documents please contact techsupport@matriksbiotek.com
Enzyme immunoassay for the quantitative determination of antibodies to Semaglutide (Ozempic®) antibodies in human serum and plasma
This kit has been especially developed for the quantitative determination of anti-semaglutide antibodies in serum and plasma samples.
This kit has been especially developed for the quantitative determination of anti-semaglutide antibodies in serum and plasma samples.
| Required Volume (µl) | 5 |
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 5 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (month) | 6 |
| Assay type | Quantitative |
| Species Reactivity | Human |
| Storage conditions | Store at +4°C. Please refer to protocols |
| Shipping conditions | At room temperature |